Evidence map›Paper›PMID 33463061›Full record

ArticleClinical and translational medicine2021

Activation of Toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction.

Xie Saiyang, Wu Qingqing, Xu Man, Liu Chen, Zhang Min, Xing Yun, Shi Wenke, Wu Haiming, Zeng Xiaofeng, Chen Si and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Xie SaiyangDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Wu QingqingDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Xu ManDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Liu ChenDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Zhang MinDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Xing YunDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Shi WenkeDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Wu HaimingDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Zeng XiaofengDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Chen SiDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Guo HaipengKey Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, Qilu Hospital of Shandong University, Jinan, China.
Deng WeiDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.ORCID 0000-0003-4883-4226
Tang QizhuDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.ORCID 0000-0003-2210-3169
Wuhan University · CNMinistry of Education · THXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs a pattern recognition receptor, Toll-like receptor 7 (TLR7) widely presented in the endosomal membrane of various cells. However, the precise role and mechanism of TLR7 in septic cardiomyopathy remain unknown. This study aims to determine the role of TLR7 in cardiac dysfunction during sepsis and explore the mechanism of TLR7 in septic cardiomyopathy.

methodsWe generated a mouse model of septic cardiomyopathy by challenging with lipopolysaccharide (LPS). TLR7-knockout (TLR7

resultsWe found that TLR7 knockout markedly exacerbated sepsis-induced systolic dysfunction. Moreover, cardiomyocytes isolated from TLR7

conclusionsOur data demonstrated that activation of TLR7 protected against sepsis-induced cardiac dysfunction through promoting cAMP-PKA-PLN pathway, and we revealed that TLR7 might be a novel therapeutic target to block the septic cardiomyopathy and support systolic function during sepsis.

Indexed as

AnimalsCardiomyopathiesDisease Models, AnimalMaleMembrane GlycoproteinsMiceMice, Inbred C57BLSepsisSystoleToll-Like Receptor 7Membrane GlycoproteinsTlr7 protein, mouseToll-Like Receptor 7Ca2+-handlingcardiac dysfunctionseptic cardiomyopathyTLR7

Identifiers

PMID33463061
PMCPMC7775988
OpenAlexW3118943258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.